INS and diabetic kidney disease: D+Q treatment was adopted as this combination has been previously reported to efficiently clear senescent APC from mouse and human cell cultures, from old as well as insulin‐resistant mice, AT from obese diabetics and individuals with diabetic kidney disease nevertheless preserving viability of cycling‐competent cells (Kirkland & Tchkonia, 2020; Zhu et al., 2015).